Although they analysed 102 EGFR-mutated lung cancer patients, only 18 non- EGFR Q787Q polymorphism cases were included in the survival analysis of EGFR mutants because of the high prevalence of the EGFR Q787Q polymorphism. This evidence concerns the gene EGFR and lung carcinoma.